VectorY Therapeutics
Biotech · Amsterdam, NL
Develops vectorised antibody treatments for neurodegenerative diseases using AAV delivery.
Funding history
| Date | Round | Amount |
|---|
| Nov 2023 | Series A Amsterdam biotech VectorY Therapeutics raised a EUR129M Series A co-led by EQT Life Sciences and the Forbion Growth Opportunities Fund. | $138M |
Investors
EQT Life SciencesForbion Growth Opportunities Fund
Similar companies in Biotech
Explore funding flow on EquityFlow →